GlassScriptPhysician profile
William M Rambo
NPI 1619079753
$28,854.75
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,001 · 2020: $8,475 · 2021: $10K · 2022: $3,234.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ctl Medical Corporation | $27,163.19 | 2019-2022 | |
| Medacta USA, INC. | $807.56 | 2019 | |
| Surgalign Spine Technologies, INC. | $195.73 | 2019 | |
| Lemaitre Vascular, INC. | $152.16 | 2019 | |
| Arbor Pharmaceuticals, INC. | $142.22 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $138.10 | 2019-2021 | |
| Spinal Elements, INC. | $92.68 | 2020 | |
| Abbott Laboratories | $34.83 | 2021 | |
| Novocure INC. | $28.70 | 2019-2020 | |
| Depuy Synthes Sales INC. | $26.13 | 2020 | |
| Medtronic USA, INC. | $17.98 | 2020 | |
| Convatec INC. | $16.22 | 2021 | |
| Smith+Nephew, INC. | $15.29 | 2022 | |
| Icotec Medical INC. | $12.00 | 2021 | |
| Endo Pharmaceuticals INC. | $11.96 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Rambo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.